New Zealand Official CrestGazette.govt.nz
Advanced search
Find a specific notice:
Notice Type
Departmental
Notice Title

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Onglyza
Saxagliptin hydrochloride 2.98mg equivalent to Saxagliptin 2.5mg
Film coated tablet
AstraZeneca Limited
Bristol-Myers Squibb Company, Indiana, United States of America

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Onglyza
Saxagliptin hydrochloride 5.95mg equivalent to Saxagliptin 5mg
Film coated tablet
AstraZeneca Limited
Bristol-Myers Squibb Company, Indiana, United States of America

Dated this 31st day of July 2015.

CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

Publication Date
6 Aug 2015

Tags

Medicines Act Consent to the distribution of new medicines Health

Notice Number

2015-go4583

Issue Number

87
Title
View PDF
Description
Principal Edition, 6 August 2015
File Type and Size
PDF (21 KB)
Page Number 0